Prothombin gene G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi Population

Thrombosis Research

Volumn 124, Issue 2, 2009, Pages 245-247

  Munshi, Anjana ^a   Kaul, Subhash ^b   Aliya, Nishat ^a   Shafi, Gowhar ^c   Alladi, Suvarna ^b   Jyothy, A ^a  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^c Research Center   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; DNA; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

3' UNTRANSLATED REGION; ALLELE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHROMOSOME 11; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; INDIA; LETTER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE PATIENT; VENOUS BLOOD;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, POPULATION; HUMANS; INDIA; INTRACRANIAL THROMBOSIS; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREVALENCE; PROTHROMBIN; RISK FACTORS; STROKE;

EID: 67349194728     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.09.013     Document Type: Letter

References (42)

1. Sacco R.L., Wolf P.A., and Gorelick P.B. Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology 53 (1999) S15-24
2. Alberts M.J. Genetics of cerebrovascular disease. Stroke 35 (2004) 342-344
3. Munshi A., and Kaul S. Int J Stroke 3 (2008) 188-192
4. Moster M.L. Coagulopatheis and arterial stroke. J Neuro-opthalmol 23 (2003) 63-71
5. Kahn M.J. Hypercoagulability as a cause of stroke in adults. South Med J 96 (2003) 350-353
6. Gulcher J.R., Gretarsdottir S., Helgadottir A., and Stefansson K. Genes contributing to risk for common forms of stroke. Trends Mol Med 11 5 (2005) 217-224
7. Degen S.J., and Davie E.W. Nucleotide sequence of the gene for human prothrombin. Biochemistry 26 (1987) 6165-6177
8. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3' untranslated region of the prothrombin gene is associated with the elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
9. Ceelie M., Bertina R.M., Spargaren-van Riel C.C., and Vos H.L. G20210A is a functional mutation: effect on protein levels and 3' end formation. J Thromb Haemostasis 2 (2004) 119-127
10. Gehring N.H., Frede U., Neu-Yilic G., Hundsdoerfer P., Vetter B., Hentze M.W., et al. Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Jenet 28 (2001) 389-392
11. Ridker P.M., Hennekens C.H., and Miletich J.P. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke and venous thrombosis in a large cohort of US men. Circulation 99 (1999) 999-1004
12. Smiles A.M., Jenny N.S., Tang Z., Arnold A., Cushman M., and Tracy R.P. No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study. J Thromb Haemost 87 (2002) 614-621
13. Lopaciuk S., Bykovska K., Kwiecinski H., et al. Factor V Leiden, prothrombin G20210A variant and methylene tetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Haemost 7 (2001) 346-350
14. de Stefano V., Cheusolo P., Pasiaroni K., and Leone G. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 91 (1998) 3562-3563
15. Casas J.P., Hingorani A.D., Bautista L.E., and Sharma P. Metanalysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61 (2004) 1652-1661
16. Meschia J.F. Subtyping in ischemic stroke genetic research. J Stroke Cerebrovasc Dis 11 5 (2002) 208-219
17. Munshi A., Shehnaz S., Kaul S., Pulla Reddy B., Alladi S., and Jyothy A. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. J Neurol Sci 272 (2008) 132-135
18. Ferraresi P., Marchetti G., Legnani C., Cavallari E., Castoldi E., Mascoli F., et al. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 17 (1997) 2418-2422
19. Franco R.F., Trip M.D., ten Cate H., Van Den Ende A., Prins M.H., Kastelein J.J., et al. The 20210 G → A mutation in the 3' untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 104 (1999) 50-54
20. Hillarp A., Zoller B., Svensson P.J., and Dhalback B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78 (1997) 990-992
21. Leroyer C., Mercler B., Oger E., Chenu E., Abgrall J.F., Ferec C., et al. Prevalence of 20210 allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 80 (1998) 49-51
22. Bertina R.M. The prothrombin 20210 G to A variation and thrombosis. Curr Opin Haematol 5 (1998) 339-342
23. Margaglione M., D'Andrea G., Giuliani N., Brancaccio V., De Lucia D., Grandone E., et al. Inherited prothrombic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 19 (1999) 1751-1756
24. Voetsch B., Damasceno B.P., Camargo E.C., Massaro A., Bacheschi A., Scaff M., et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 82 (2000) 229-233
25. Longstreth Jr. W.T., Rosendaal F.R., Siscovick D.S., et al. Risk of stroke in young women and two prothrombotic mutation: Factor V leiden and prothrombin gene variant (G20210A). Stroke 29 (1998) 577-580
26. Gerdes VE., ten Cate H., de Groot E., Kwa V.I., Prins MH., Reistsma PH., et al. Arterial wall thickness and the risk of recurrent ischemic events in carriers of the thrombin G20210A mutation with clinical manifestations of atherosclerosis. Atherosclerosis 163 (2002) 135-140
27. Bushnell C.D., and Goldstein L.B. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31 (2000) 3067-3078
28. Eby Charles S. Prothrombic states in ischemic stroke. Semin Cerebrovasc Dis Stroke 2 2 (2002) 90-101
29. Rosendaal F.R., Siscovick D.S., Schwartz S.M., Psaty B.M., Raghunanthan T.E., and Vas H.L. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 90 (1997) 1747-1750
30. Doggen CJ, Cats VM, Bertina RM and Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V leiden or prothrombin 20210A. Circulation 1998; 97: 1037-41.
31. Andler G and Mannhalter C.Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 330 (2003) 31-55
32. Herrman F.H., Salazar-Sanchez, Schröder W., Grimm R., Schuster G., Jimennez-Arceg, et al. Prevalence of Molecular Risk Factors FV Leiden, FVHR2. FII 20210G>A in Different Populations and Ethnic Groups of Germany, Costa Rica and India. IJHG 1 1 (2001) 33-39
33. Garewal G., Das R., Ahluwalia J., Mittal N., and Varma S. Prothrombin G20210A is not prevalent in North India. J Thromb Haemost 1 (2003) 2253-2254
34. Gupta N., Khan F., Tripathi M., Singh V.P., Tewari S., Ramesh V., et al. Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India. Indian J Med Sci S7 12 (2003) 535-542
35. Ghosh K., Shetty S., Madkaikar M., Pawar A., Nair S., Khare A., et al. Venous thromboembolism in young patients from western India: A study. Clin Appl Thromb Haemost 7 (2001) 158-165
36. Ghosh K., Khare A., Kulkarni B., Shetty S., and Mohanty D. Geography too determines the causes of inherited thrombophilia. J Thromb Haemost 2 (2004) 363-364
37. Rees D.C., Chapman N.H., Webster H.T., Guerreiro J.F., Rochette J., and Clegg J.B. Born to clot: the European burden. Br J Haematol 105 (1999) 564-566
38. Angeline T., Bentley H.A., Hawk A.B., Manners R.J., Mokashi H.A., Jeyaraj N., et al. Prevalence of Factor VG191A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp and Mol Path 79 (2005) 9-13
39. Dindagur N., Kruthika-Vinod T.P., and Christopher R. Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis. J Neurol Sci 249 (2006) 25-30
40. Franco R.F., Santos S.E.B., Elion J., Tavella M.M., and Zago M.A. Prevalence of the G20210A polymorphism in the 3' untranslated region of the prothrombin gene in different human populations. Acta Haematol 100 (1998) 9-12
41. Murata M. Genetic polymorphisms associated with the thrombotic disorders in the Japanese population. Fibrinolysis Proteolysis 14 2/3 (2000) 155-164
42. Zivelin A., Rosenberg N., Faiers S., Kornbort N., Peretz H., Mannhaltor C., et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 92 (1998) 1119-1124